Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Ascher

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Journal of Cosmetic Dermatology|March 4, 2026
Non-Surgical Hip Augmentation With a PDLLA-Hyaluronic AcidHan Earl Lee, Jovian Wan, Ki Woong Yu, et al.
Aesthetic Surgery Journal. Open Forum|May 22, 2023
The Effect of Hybrosome (Umbilical Cord Blood Exosome-Liposome Hybrid Vesicles) on Human Dermal Cells In VitroPolen Koçak, Naz Unsal, Serli Canikyan, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|August 22, 2006
Full scope of effect of facial lipoatrophy: a framework of disease understandingBenjamin Ascher, Sydney Coleman, Tina Alster, et al.
Aesthetic Surgery Journal|February 16, 2017
Liquid Formulation of AbobotulinumtoxinA Exhibits a Favorable Efficacy and Safety Profile in Moderate to Severe Glabellar Lines: A Randomized, Double-Blind, Placebo- and Active Comparator-Controlled TrialBenjamin Ascher, Philippe Kestemont, Dominique Boineau, et al.
Aesthetic Surgery Journal|July 25, 2023
International Consensus Recommendations on the Aesthetic Usage of Ready-to-Use AbobotulinumtoxinA (Alluzience)Benjamin Ascher, Berthold-Josef Rzany, Philippe Kestemont, et al.
Aesthetic Surgery Journal|September 25, 2019
Significantly Increased Patient Satisfaction Following Liquid Formulation AbobotulinumtoxinA Treatment in Glabellar Lines: FACE-Q Outcomes From a Phase 3 Clinical TrialBenjamin Ascher, Berthold Rzany, Philippe Kestemont, et al.
JPRAS Open|March 2, 2026
Compensatory hypertrophy of the superior gluteus maximus following botulinum toxin-induced weakening of the inferior fibersKyu-Ho Yi, Jin-Hyun Kim, Isabella Rosellini, et al.
Aesthetic Surgery Journal|March 21, 2019
Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar LinesBenjamin Ascher, Berthold Rzany, Philippe Kestemont, et al.
Journal of Cosmetic Dermatology|July 15, 2020
Clinical validation of the temporal lifting technique using soft tissue fillersClaudia A Hernandez, David L Freytag, Michael H Gold, et al.
JPRAS Open|January 16, 2026
Ultrasound-guided injection of ankle contouring with botulinum neurotoxinKyu-Ho Yi, Jin-Hyun Kim, Jong-Keun Song, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Journal of Cosmetic Dermatology|March 4, 2026
Non-Surgical Hip Augmentation With a PDLLA-Hyaluronic AcidHan Earl Lee, Jovian Wan, Ki Woong Yu, et al.
Aesthetic Surgery Journal. Open Forum|May 22, 2023
The Effect of Hybrosome (Umbilical Cord Blood Exosome-Liposome Hybrid Vesicles) on Human Dermal Cells In VitroPolen Koçak, Naz Unsal, Serli Canikyan, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|August 22, 2006
Full scope of effect of facial lipoatrophy: a framework of disease understandingBenjamin Ascher, Sydney Coleman, Tina Alster, et al.
Aesthetic Surgery Journal|February 16, 2017
Liquid Formulation of AbobotulinumtoxinA Exhibits a Favorable Efficacy and Safety Profile in Moderate to Severe Glabellar Lines: A Randomized, Double-Blind, Placebo- and Active Comparator-Controlled TrialBenjamin Ascher, Philippe Kestemont, Dominique Boineau, et al.
Aesthetic Surgery Journal|July 25, 2023
International Consensus Recommendations on the Aesthetic Usage of Ready-to-Use AbobotulinumtoxinA (Alluzience)Benjamin Ascher, Berthold-Josef Rzany, Philippe Kestemont, et al.
Aesthetic Surgery Journal|September 25, 2019
Significantly Increased Patient Satisfaction Following Liquid Formulation AbobotulinumtoxinA Treatment in Glabellar Lines: FACE-Q Outcomes From a Phase 3 Clinical TrialBenjamin Ascher, Berthold Rzany, Philippe Kestemont, et al.
JPRAS Open|March 2, 2026
Compensatory hypertrophy of the superior gluteus maximus following botulinum toxin-induced weakening of the inferior fibersKyu-Ho Yi, Jin-Hyun Kim, Isabella Rosellini, et al.
Aesthetic Surgery Journal|March 21, 2019
Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar LinesBenjamin Ascher, Berthold Rzany, Philippe Kestemont, et al.
Journal of Cosmetic Dermatology|July 15, 2020
Clinical validation of the temporal lifting technique using soft tissue fillersClaudia A Hernandez, David L Freytag, Michael H Gold, et al.
JPRAS Open|January 16, 2026
Ultrasound-guided injection of ankle contouring with botulinum neurotoxinKyu-Ho Yi, Jin-Hyun Kim, Jong-Keun Song, et al.
Pageof 6